Home  >  News
News
+ Font Resize -

NPPA fixes retail prices of 14 scheduled formulations of Schedule-I under DPCO, 2013

Our Bureau, Mumbai
Tuesday, January 2, 2018, 16:00 Hrs  [IST]

The National Pharmaceutical Pricing Authority (NPPA) has recently fixed retail prices of 14 formulations under Drugs (Prices Control) Order, 2013.

The scheduled formulations are Cilnidipine + Metoprolol Tablet, Metformin + Glimepiride + Voglibose Tablets, Rosuvastatin + Clopidogrel Capsule, Telmisartan + Chlorthalidone Tablet (Tigatel CH 80), Rosuvastatin + Clopidogrel Capsule, Paracetamol+Caffeine+ Phenylephrine+ Diphenhydramine Tablet (Sinus77), Atorvastatin + Clopidogrel Capsule, Gliclazide + Metformin Tablet (Glychek M + ) Atorvastatin + Clopidogrel Capsule (Atocor CV 20mg) and Atorvastatin + Clopidogrel Capsule (Avas 20 Gold)

The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form - III of Schedule - II of the DPCO, 2013 through IPDMS.

Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form -IV of Schedule - II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.

Consequent to the issue of ceiling prices of such formulations as specified, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

 

Post Your commentsPOST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
ipc_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |